The Global Viral Vector and Plasmid Manufacturing Market is projected to reach USD 1.12 billion in 2027. An increase in the number of advanced biotechnology and pharmaceutical discovery programs is expected to drive market investment. Approximately 70% of these therapies, there are over 700 cell and gene therapies in clinical trials, and vectors. The production rate was therefore...